Kozicky, Lisa K <br/><br/>
Intravenous immunoglobulin (IVIg) or IVIg-treated macrophages reduce DSS-induced colitis by inducing macrophage IL-10 production.  [electronic resource] 

 -  European journal of immunology  08 2019 
 - 1251-1268 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-4141 
<br/><br/><label>Standard No.: </label>10.1002/eji.201848014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adoptive Transfer<br/>Animals<br/>Cell Differentiation<br/>Cells, Cultured<br/>Colitis--chemically induced<br/>Colon--metabolism<br/>Dextran Sulfate<br/>Disease Models, Animal<br/>Humans<br/>Immunoglobulins, Intravenous--therapeutic use<br/>Inflammation Mediators--metabolism<br/>Inflammatory Bowel Diseases--drug therapy<br/>Interleukin-10--genetics<br/>Macrophages--drug effects<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Mice, Knockout